We are live on ! Find out more
DMIIR

Drugs Made In America Acquisition II Corp Right
DMIIR

47 hedge funds and large institutions have $4.53M invested in Drugs Made In America Acquisition II Corp Right in 2025 Q4 according to their latest regulatory filings, with 47 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
+47
Holders Change %
–
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
47
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MF
Magnetar Financial
Illinois
+$386K
2
FTCM
First Trust Capital Management
Illinois
+$295K
3
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$281K
4
GCL
Glazer Capital LLC
New York
+$271K
5
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
+$233K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MF
1
Magnetar Financial
Illinois
$378K +$386K +2,700,000 New
FTCM
2
First Trust Capital Management
Illinois
$290K +$295K +2,068,118 New
Hudson Bay Capital Management
3
Hudson Bay Capital Management
Connecticut
$276K +$281K +1,969,030 New
GCL
4
Glazer Capital LLC
New York
$266K +$271K +1,899,899 New
Toronto Dominion Bank
5
Toronto Dominion Bank
Ontario, Canada
$229K +$233K +1,633,000 New
Millennium Management
6
Millennium Management
New York
$210K +$214K +1,500,000 New
PAMP
7
Polar Asset Management Partners
Ontario, Canada
$210K +$214K +1,500,000 New
TCM
8
Tenor Capital Management
New York
$210K +$214K +1,500,000 New
HIM
9
HGC Investment Management
Ontario, Canada
$172K +$176K +1,230,980 New
AA
10
AQR Arbitrage
Connecticut
$161K +$164K +1,151,400 New
AC
11
Aristeia Capital
Connecticut
$154K +$157K +1,100,000 New
DKCM
12
Davidson Kempner Capital Management
New York
$140K +$143K +1,000,000 New
D.E. Shaw & Co
13
D.E. Shaw & Co
New York
$140K +$143K +1,000,000 New
OAC
14
OMERS Administration Corp
Ontario, Canada
$140K +$143K +1,000,000 New
PMAM
15
Picton Mahoney Asset Management
Ontario, Canada
$123K +$125K +875,000 New
LA
16
Linden Advisors
New York
$117K +$129K +899,899 New
CL
17
CSS LLC
Illinois
$113K +$11.5K +80,600 New
CCM
18
Context Capital Management
California
$105K +$107K +750,000 New
GCM
19
Ghisallo Capital Management
Massachusetts
$105K +$107K +750,000 New
MCM
20
Moore Capital Management
New York
$105K +$107K +750,000 New
RCM
21
Radcliffe Capital Management
Pennsylvania
$74.8K +$82.1K +575,000 New
SCM
22
Shaolin Capital Management
Florida
$73.5K +$75K +525,000 New
WAM
23
Wolverine Asset Management
Illinois
$70.7K +$72.1K +505,057 New
HI
24
HBK Investments
Texas
$70K +$71.4K +500,000 New
WA
25
Whitebox Advisors
Minnesota
$63K +$64.3K +450,000 New
1
2

DMIIR Hedge Fund Activity: Q4 2025 in Review

47 of the 8,256 institutional investors tracked by Wall St. Rank reported a position in Drugs Made In America Acquisition II Corp Right (DMIIR) for Q4 2025, worth a combined $4.53M.

Buyers outnumbered sellers: 47 funds opened new DMIIR positions and 0 closed out — a net gain of 47 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Magnetar Financial, opening a new position worth an estimated $386K.

  • 47 institutional investors held Drugs Made In America Acquisition II Corp Right (DMIIR) as of Q4 2025, up from 0 in Q3 2025.
  • Funds reported $4.53M of Drugs Made In America Acquisition II Corp Right stock for Q4 2025.
  • 47 funds opened new Drugs Made In America Acquisition II Corp Right positions in Q4 2025 and 0 closed out, a net change of +47 holders.
  • The largest Drugs Made In America Acquisition II Corp Right buyer in Q4 2025 was Magnetar Financial, an estimated $386K added.

Based on aggregated 13F filings for Q4 2025.